Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation

NCT06604611 is registered in ClinicalTrials.gov with Dongying Zhang as lead sponsor.

NCT NCT06604611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06604611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation
Lead sponsor
Dongying Zhang
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
March 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammation, colchicine, heart failure, heart failure with preserved ejection fraction (hfpef), inflammation